SLC7A11 and SLC3A2 are subunits of the cystine/glutamate antiporter xCT, and the expression of GPX4 driven by xCT determines the sensitivity of BC cells to ferroptosis inducers [16]. This evidence concerns the gene SLC3A2 and breast cancer.